Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's Adverse Event Reporting System and review of case reports in the literature.
Raisch DW, Garg V, Arabyat R, Shen X, Edwards BJ, Miller FH, McKoy JM, Nardone B, West DP. Raisch DW, et al. Among authors: edwards bj. Expert Opin Drug Saf. 2014 Jan;13(1):15-23. doi: 10.1517/14740338.2013.832752. Epub 2013 Sep 20. Expert Opin Drug Saf. 2014. PMID: 24053773 Review.
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report.
Edwards BJ, Laumann AE, Nardone B, Miller FH, Restaino J, Raisch DW, McKoy JM, Hammel JA, Bhatt K, Bauer K, Samaras AT, Fisher MJ, Bull C, Saddleton E, Belknap SM, Thomsen HS, Kanal E, Cowper SE, Abu Alfa AK, West DP. Edwards BJ, et al. Br J Radiol. 2014 Oct;87(1042):20140307. doi: 10.1259/bjr.20140307. Br J Radiol. 2014. PMID: 25230161 Free PMC article.
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.
Edwards BJ, Bunta AD, Lane J, Odvina C, Rao DS, Raisch DW, McKoy JM, Omar I, Belknap SM, Garg V, Hahr AJ, Samaras AT, Fisher MJ, West DP, Langman CB, Stern PH. Edwards BJ, et al. J Bone Joint Surg Am. 2013 Feb 20;95(4):297-307. doi: 10.2106/JBJS.K.01181. J Bone Joint Surg Am. 2013. PMID: 23426763 Free PMC article. Review.
Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.
Nardone B, Saddleton E, Laumann AE, Edwards BJ, Raisch DW, McKoy JM, Belknap SM, Bull C, Haryani A, Cowper SE, Abu-Alfa AK, Miller FH, Godinez-Puig V, Dharnidharka VR, West DP. Nardone B, et al. Among authors: edwards bj. Pediatr Radiol. 2014 Feb;44(2):173-80. doi: 10.1007/s00247-013-2795-x. Epub 2013 Sep 21. Pediatr Radiol. 2014. PMID: 24057195 Free PMC article.
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.
Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL. Dorr DA, et al. Among authors: edwards bj. Clin Cancer Res. 2009 Jun 1;15(11):3850-5. doi: 10.1158/1078-0432.CCR-08-1811. Epub 2009 May 19. Clin Cancer Res. 2009. PMID: 19458059 Free PMC article.
159 results